Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 16;16(1):231.
doi: 10.1186/s13098-024-01465-y.

Lipid metabolites and sarcopenia-related traits: a Mendelian randomization study

Jianping Liu  1 , Sufang Wang  1 , Yuan Shen  1 , Haicun Shi  1 , Lijian Han  2
Affiliations

Lipid metabolites and sarcopenia-related traits: a Mendelian randomization study

Jianping Liu et al. Diabetol Metab Syndr. .

Abstract

Objective: To explore the influence of lipid metabolism on the risk of sarcopenia.

Methods: Two-sample Mendelian randomization (MR) analysis was used to determine causality. A total of 179 lipid metabolism data points were used for exposure, and the data were obtained from a plasma lipid metabolite study of 7174 participants. The total muscle mass and total muscle strength, as well as the muscle strength and muscle mass of different sex groups, were selected as the relevant traits of sarcopenia. Data for outcomes were obtained from the UK Biobank, and sample sizes ranged from 135 468 to 450 243. Inverse-variance weighted (IVW), as the main method for evaluating the causal relationship between lipid metabolites and sarcopenia, uses the false discovery rate (FDR) for multiple comparisons and conducts heterogeneity, pleiotropy, and reverse causality tests.

Results: Twenty-seven lipid metabolites, mainly phosphatidylcholine, phosphatidylethanolamine, ceramide, triacylglycerol, sphingomyelin, and sterol ester, were found to be associated with the risk of sarcopenia. Ceramide (d40:1), ceramide (d40:2), and sterol ester are risk factors for decreased muscle mass and strength. There is a positive causal relationship between various phosphatidylcholine lipids and muscle mass and strength. Sphingomyelin (d42:2) is a protective factor for total muscle strength and female muscle strength. There are inconsistent effects between different lipid metabolites, triacylglycerol, and muscle strength and muscle mass.

Conclusions: There was a causal relationship between 27 lipid metabolites and sarcopenia traits, and targeting specific lipid metabolites may benefit sarcopenia diagnosis, disease assessment, and treatment.

Keywords: Mendelian randomization, lipid metabolites; Muscle mass; Muscle strength; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Heat map show the results of five Mendelian randomization methods
Fig. 2
Fig. 2
displays the heterogeneity and pleiotropy analysis results of lipid metabolites which have casual effects with muscle strength (A) and muscle mass (B)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Yuan S, Larsson SC. Epidemiology of Sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. - PubMed
    1. Xia L, et al. Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies. Cancer Med. 2020;9:7964–78. - PMC - PubMed
    1. Murphy CH, et al. Prevalence and determinants of Sarcopenia in community-dwelling older adults in Ireland. Aging Clin Exp Res. 2023;35:1651–60. - PubMed
    1. Riuzzi F, et al. Cellular and molecular mechanisms of Sarcopenia: the S100B perspective. J Cachexia Sarcopenia Muscle. 2018;9:1255–68. - PMC - PubMed
    1. Lipina C, Hundal HS. Lipid modulation of skeletal muscle mass and function. J Cachexia Sarcopenia Muscle. 2017;8:190–201. - PMC - PubMed

LinkOut - more resources